pharmaphorum

JANUARY 21, 2022

Medical science is accelerating at a tremendous rate, leading to profound changes in the treatment landscape for many diseases over the last decade. “It And the bottom line is that the patient may not receive a medicine that could save or substantially improve his or her life.”. Flawed funding model. WHO is OMI?

Insurance 52

Insurance Vaccines 52

ISPE

DECEMBER 1, 2022

The picture of the life sciences industry is clearly that of a healthy and constantly growing sector, as we are seeing an estimated increase in sales of over 4.6%, which will lead to the achievement of 1.5 trillion dollars in global turnover. Micaela Prati. perspective. . Learn More about Italy Affiliate.

98

98

pharmaphorum

NOVEMBER 27, 2022

Automation will be a large part of this long-term vision. Neil Keegan is head of manufacturing at Automata, a London-based biotech company providing robotic automation solutions to the life sciences industry. About the author.

Communication 103

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 103

ISPE

JANUARY 9, 2023

™ technologies to CPV programs will enable this vision for predictive monitoring by making it technically feasible to: Predict deviations more accurately with artificial intelligence (AI)/machine learning (ML) algorithms Perform RCA from a holistic viewpoint Ensure data integrity and GxP compliance in predictions and RCA Thinking further, CPV 4.0

Documentation 52

Documentation Communication 52